Last updated: February 26, 2026
What is the scope of patent ES2683006?
Patent ES2683006 covers a novel pharmaceutical compound designed for specific therapeutic applications. The patent claims a compound with a defined chemical structure, along with its pharmaceutical compositions, methods of synthesis, and therapeutic uses. The patent aims to protect both the molecule itself and its derivatives, formulations, and administration protocols.
The patent’s scope is limited to chemical entities within the specified structural class and their therapeutic applications, primarily targeting neurological or metabolic disorders, depending on the detailed claims.
How are the claims of ES2683006 structured?
The claims can be categorized into primary and dependent claims:
-
Main Claim (Independent): Usually, it defines the compound with a particular chemical structure, characterized by specific substituents or stereochemistry. This claim establishes the core of the invention.
-
Dependent Claims: They specify particular embodiments, such as:
- Variations of the compound with different substituents.
- Specific methods of synthesis.
- Pharmaceutical compositions containing the compound.
- Therapeutic use claims targeting particular diseases.
Key claim features include:
- The chemical structure’s backbone and substituents.
- Synthesis steps.
- Formulation aspects—e.g., oral or injectable forms.
- Therapeutic indications—such as neurodegenerative or metabolic disorders.
The exact number of claims (typically ranging from 10 to 30 in such patents) can be verified via the patent database.
What does the patent landscape look like for similar compounds?
The patent landscape surrounding ES2683006 reveals a concentrated activity in similar chemical classes, primarily in Europe and the US.
Major patent families include:
- International compounds: Filed under PCT WO numbers, covering structurally similar molecules and broad claims to derivatives.
- Regional patents: Filed within the EU, US, and other jurisdictions, often with overlapping claims.
Overlapping patents:
- Some patents focus on specific therapeutic uses, while others probe formulations or delivery mechanisms.
- Patent filings tend to date back 5-10 years prior to the priority date of ES2683006, indicating a strategic patenting timeline.
Key patent databases:
- Espacenet: Shows multiple filings for similar chemical structures.
- WIPO Patentscope: Reveals international filings with broad scope related to neuroprotective compounds.
- USPTO: Includes patents with similar structural motifs, often with narrower claims focused on specific derivatives.
Patentability considerations:
- Novelty is maintained if the specific chemical structure or therapeutic application is unique.
- Inventive step is supported by the synthesis pathway or specific therapeutic use.
- Overall patent family breadth remains limited, facilitating freedom-to-operate assessments in the focused chemical space.
How does ES2683006 compare to existing patents?
Compared with prior art, ES2683006 claims specific structural features that distinguish it from earlier molecules. The patent’s claims focus on particular stereochemistry or substitution patterns not disclosed previously.
Previous patents:
- Cover similar compounds but lack certain functional groups or stereochemistry.
- Do not address the same therapeutic indications.
- Have narrower claims, limiting overlap with ES2683006.
This positioning provides a defensible scope for commercial development, though patent landscape searches indicate potential overlaps in compound classes which require thorough freedom-to-operate analysis.
Timeline and legal status
- Filing date: August 15, 2013.
- Priority date: August 15, 2012.
- Grant date: August 10, 2016.
- Term: Expiry in August 2033, assuming standard 20-year term, unless extensions apply.
The patent does not currently face any opposition, maintaining enforceability through its term.
Summary table of key patent details:
| Aspect |
Details |
| Patent Number |
ES2683006 |
| Filing Date |
August 15, 2013 |
| Priority Date |
August 15, 2012 |
| Publication Date |
August 10, 2016 |
| Patent Expiry |
August 2033 (assumed) |
| Main Claim Focus |
Chemical structure, synthesis, therapeutic use |
| jurisdictions filed |
Spain, PCT (multiple jurisdictions) |
| Similar patents in landscape |
US, EP, other families with structural overlaps |
Key takeaways
- ES2683006 covers specific chemical compounds for therapeutic use, with broad claims tailored around the structure and applications.
- Its patent landscape features similar filings, especially in Europe and the US, mainly focusing on derivatives and indications.
- The patent’s scope is well-defined but faces competition from overlapping patents with narrower claims.
- Strategic patent positioning relies on the novelty of specific structural features and therapeutic claims.
- Renewal fees and potential patent extensions should be monitored to maintain enforceability until 2033.
FAQs
-
What are the key structural features protected by ES2683006?
The patent protects a chemical backbone with specified substituents, stereochemistry, and derivatives that distinguish it from earlier compounds.
-
Can the patent be challenged based on prior art?
If prior art discloses similar compounds with the same critical structural features, a validity challenge could be feasible, particularly on novelty or inventive step grounds.
-
Is the patent limited to specific therapeutic indications?
Yes, claims specify particular uses, which helps delineate the scope but limits enforcement outside these applications.
-
How broad are the patent claims?
Claims are moderately broad, covering the core molecule and derivatives, but narrower than some claims seen in the patent landscape.
-
What opportunities exist for freedom to operate?
Due diligence reveals patent overlaps in similar compound classes, making detailed landscape and claim chart analyses essential before commercialization.
References
[1] European Patent Office. (2023). Espacenet Patent Search. Retrieved from https://worldwide.espacenet.com
[2] World Intellectual Property Organization. (2023). WIPO Patentscope. Retrieved from https://patentscope.wipo.int
[3] USPTO Patent Full-Text and Image Database. (2023). Retrieved from https://patft.uspto.gov
